StemCell2MAX
Biotechnology - Cantanhede, , Portugal
StemCell2MAX Employees
StemCell2MAX Details
StemCell2MAX is a biotechnology start-up that owns a proprietary solution for multiplying blood stem cells. Blood stem cells are required for both research and blood cancer treatment, but these are scarce resulting in limited transplants, patient death and limitations at research level. StemCell2MAX addresses this enormous demand from patients, cord blood banks, hospitals and researchers. Research market: Currently, StemCell2MAX markets StemCell2MAX Mix for research use only with a growing sales track record, both in EU and USA. Clinical market: Following the technology's market acceptance and scientific recognition, StemCell2MAX is preparing StemCell2MAX Med for the clinical market. The innovation is protected in EU, USA and Japan for blood stem cell maintenance, expansion or transplantation, for both research and clinical use.
